E2 enzymes: more than just middle men

MD Stewart, T Ritterhoff, RE Klevit, PS Brzovic - Cell research, 2016 - nature.com
Ubiquitin-conjugating enzymes (E2s) are the central players in the trio of enzymes
responsible for the attachment of ubiquitin (Ub) to cellular proteins. Humans have∼ 40 E2s …

From discovery to bedside: targeting the ubiquitin system

IE Wertz, X Wang - Cell chemical biology, 2019 - cell.com
The ubiquitin/proteasome system is a primary conduit for selective intracellular protein
degradation. Since its discovery over 30 years ago, this highly regulated system continues to …

A RAD18–UBC13–PALB2–RNF168 axis mediates replication fork recovery in BRCA1-deficient cancer cells

E Cybulla, S Wallace, A Meroni, J Jackson… - Nucleic acids …, 2024 - academic.oup.com
BRCA1/2 proteins function in genome stability by promoting repair of double-stranded DNA
breaks through homologous recombination and by protecting stalled replication forks from …

The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13

F Mulas, X Wang, S Song, G Nishanth, W Yi… - Cellular & molecular …, 2021 - nature.com
Dendritic cells (DCs) are indispensable for defense against pathogens but may also
contribute to immunopathology. Activation of DCs upon the sensing of pathogens by Toll-like …

[HTML][HTML] Ubc13: the Lys63 ubiquitin chain building machine

CD Hodge, L Spyracopoulos, JNM Glover - Oncotarget, 2016 - ncbi.nlm.nih.gov
Ubc13 is an ubiquitin E2 conjugating enzyme that participates with many different E3 ligases
to form lysine 63-linked (Lys63) ubiquitin chains that are critical to signaling in inflammatory …

Emerging drug development technologies targeting ubiquitination for cancer therapeutics

G Veggiani, MCR Gerpe, SS Sidhu, W Zhang - Pharmacology & …, 2019 - Elsevier
Abstract Development of effective cancer therapeutic strategies relies on our ability to
interfere with cellular processes that are dysregulated in tumors. Given the essential role of …

Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia

L Barreyro, AM Sampson, C Ishikawa… - Science translational …, 2022 - science.org
Dysregulation of innate immune signaling pathways is implicated in various hematologic
malignancies. However, these pathways have not been systematically examined in acute …

Technologies for Direct Detection of Covalent Protein–Drug Adducts

E Mons, RQ Kim, MPC Mulder - Pharmaceuticals, 2023 - mdpi.com
In the past two decades, drug candidates with a covalent binding mode have gained the
interest of medicinal chemists, as several covalent anticancer drugs have successfully …

The effect of dysfunctional ubiquitin enzymes in the pathogenesis of most common diseases

G Celebi, H Kesim, E Ozer, O Kutlu - International journal of molecular …, 2020 - mdpi.com
Ubiquitination is a multi-step enzymatic process that involves the marking of a substrate
protein by bonding a ubiquitin and protein for proteolytic degradation mainly via the ubiquitin …

UBE2N promotes melanoma growth via MEK/FRA1/SOX10 signaling

A Dikshit, YJ Jin, S Degan, J Hwang, MW Foster, CY Li… - Cancer research, 2018 - AACR
Abstract UBE2N is a K63-specific ubiquitin conjugase linked to various immune disorders
and cancer. Here, we demonstrate that UBE2N and its partners UBE2V1 and UBE2V2 are …